SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027821
Filing Date
2016-11-07
Accepted
2016-11-07 08:31:11
Documents
69
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q srpt-10q_20160930.htm 10-Q 2396695
2 EX-10.1 srpt-ex101_282.htm EX-10.1 106732
3 EX-10.2 srpt-ex102_283.htm EX-10.2 1025731
4 EX-31.1 srpt-ex311_9.htm EX-31.1 10552
5 EX-31.2 srpt-ex312_7.htm EX-31.2 10641
6 EX-32.1 srpt-ex321_6.htm EX-32.1 7257
7 EX-32.2 srpt-ex322_8.htm EX-32.2 7336
  Complete submission text file 0001564590-16-027821.txt   7745056

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT srpt-20160930.xml EX-101.INS 1348914
9 XBRL TAXONOMY EXTENSION SCHEMA srpt-20160930.xsd EX-101.SCH 42246
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20160930_cal.xml EX-101.CAL 46010
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20160930_def.xml EX-101.DEF 89264
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20160930_lab.xml EX-101.LAB 276752
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20160930_pre.xml EX-101.PRE 224086
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 161976653
SIC: 2834 Pharmaceutical Preparations